Trial Site Detail

 

Drug:
IDRX-42
Trial:
A First-in-human (FIH) Study of IDRX-42 in Participants With Metastatic and/or Unresectable Gastrointestinal Stromal Tumors (GIST) [Study ID: StrateGIST1]
Conditions: Gastrointestinal Stromal Tumor
Trial Status:
Recruiting

 

Helios Klinikum Berlin-Buch

Schwanebecker Chaussee     13125
Berlin ,
Germany

 

Principal Investigator:
 Annette Reichardt, MD
Contact:
 annette.reichardt@helios-gesungheit.de +49 30 9401-14852
Activation Status of this Site:
 Active
Notes about this Site:
Helios Klinikum Berlin-Buch Website:

 

 

Navigating the Map

Use the plus (+) and minus (-) controls to zoom in/out.

Click and drag the map or use the arrows to move (pan) the map.

Tip: Click the marker before zooming and the map will stay centered on the marker as you zoom.